510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2179-2013Class II

Monoject 0.9% Sodium Chloride Flush Syringe, 12 mL Syringe with 3 mL Fill Product ID: 8881570123

Medtronic, Inc. / initiated 2013-08-16 / Terminated / root cause: manufacturing process

Covidien LLC began a recall of Monoject 0.9% Sodium Chloride Flush Syringe, 12 mL Syringe with 3 mL Fill Product ID: 8881570123 Product Usage: Both 0.9% Sodium Chloride Flush syringes and... on . FDA classified it as Class II and gives the reason as "Monoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2179-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Medtronic, Inc.
Product
Monoject 0.9% Sodium Chloride Flush Syringe, 12 mL Syringe with 3 mL Fill Product ID: 8881570123 Product Usage: Both 0.9% Sodium Chloride Flush syringes and 10U/mL or 100U/mL Heparin Lock Flush syringes are sterile, single-use products which are intended for use in flushing and locking compatible intravenous administration sets and indwelling intravenous access devices
Product code
NGT Saline, Vascular Access Flush
Reason for recall
Monoject prefill flush syringes may contain non-sterile water and labeled as saline or heparin
Root cause tag
manufacturing process
FDA root cause
Process control
Action
Covidien sent an Urgent Medical Device Recall letter dated August 16, 2013 via Federal Express to all affected customers. The letter identified the affected product, problem and actions to be taken. The letter requested that customers immediately quarantine and discontinue use of the affected products, return any affected product by following the instructions provided in the letter, and complete and return the Recalled Product Return Form to Covidien. The letter states that if the affected products have been distributed, assure that all customers are notified and affected product is removed from the distribution channel as well as from customer stock. Questions or concerns, please do not hesitate to contact your Covidien representative or Covidien Customer Service, Monday through Friday, 8am- 6:30pm ET, at (800) 962-9888, option 1, and then option 2. Firm issued Press on 8/19/13
Quantity in commerce
Unknown
Distribution
Worldwide Distribution - USA Nationwide and the country of Bermuda
Product codes and lots
Lot Numbers:  13A0084N

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2179-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2178-2013Class IITerminatedVoluntary: Firm initiated
Z-2179-2013Class IITerminatedVoluntary: Firm initiated
Z-2180-2013Class IITerminatedVoluntary: Firm initiated
Z-2181-2013Class IITerminatedVoluntary: Firm initiated
Z-2182-2013Class IITerminatedVoluntary: Firm initiated
Z-2183-2013Class IITerminatedVoluntary: Firm initiated
Z-2184-2013Class IITerminatedVoluntary: Firm initiated
Z-2185-2013Class IITerminatedVoluntary: Firm initiated
Z-2186-2013Class IITerminatedVoluntary: Firm initiated